Date: 2011-10-12
Type of information: R&D agreement
Compound:
Company: Galapagos (Belgium) Chiesi (Italy)
Therapeutic area:
Type agreement: research - R&D
Action mechanism:
Disease:
Details: Galapagos ‘s BioFocus service division has extended its collaboration with Chiesi Farmaceutici. This extension of the collaboration with Chiesi is valued at €2.8 million. BioFocus and Chiesi began their collaboration in December 2009 and have now extended the agreement for a second time, until the end of 2012. Under the terms of the integrated collaboration agreement, BioFocus will provide expanded medicinal chemistry resource, biology services, and an option to perform ADME services, for an undisclosed Chiesi therapeutic program.
Financial terms:
Latest news:
